---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-26-000005"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2026-03-24T23:59:59+00:00"
generated_at: "2026-05-15T09:12:32.881923+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medtronic cuts FY2026 EPS guidance on MiniMed charges; FDA clears MiniMed Flex pump

## Summary
- FDA cleared MiniMed Flex insulin pump several months earlier than expected; smartphone-controlled.
- One-time $157M charge in Q4 FY2026 due to Blackstone royalty arrangement; $0.08 EPS impact.
- MiniMed IPO (10% stake) closed Mar 9; dilutes Medtronic EPS by $0.04 in Q4 FY2026.
- FY2026 non-GAAP EPS guidance revised to $5.50-$5.54 from $5.62-$5.66.
- FY2027 high single-digit EPS growth guidance unchanged; Blackstone earns mid-to-high single digit royalty on first two years of net sales.

## SEC filing metadata
- accession: 0001613103-26-000005
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2026-03-24T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/0001613103-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-26-000005
- JSON: https://secwatch.observer/filing/0001613103-26-000005.json
- Plain text: https://secwatch.observer/filing/0001613103-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
